Concept Architecture
Concept
Theoretically, Positive Externality is a form of market failure in which the production or consumption of a good or service generates uncompensated benefits for third parties. Because these external benefits are not fully considered by private decision-makers, markets produce or consume less than the socially optimal quantity. In health economics, positive externalities commonly arise from vaccination, disease surveillance, health education, antimicrobial stewardship, and other public health interventions that improve the health of individuals beyond the direct recipient.
Mathematically, a positive externality is represented by marginal social benefit exceeding marginal private benefit. The divergence between private and social benefits causes the competitive market equilibrium to underprovide the good or service relative to the socially efficient outcome. Welfare is maximised when marginal social benefit equals marginal social cost.
In practice, positive externalities are estimated using epidemiological, clinical, and economic data to quantify indirect benefits such as herd immunity, reduced disease transmission, or improved population productivity. Health economists incorporate these spillover benefits into cost-effectiveness analyses, cost-benefit analyses, and policy evaluations when assessing interventions that generate population-wide health gains.
Purpose
Used to quantify spillover health benefits affecting third parties, supporting analyses of market failure, public health interventions, and economic evaluation.
Mathematical Formulae
Primary Formula
MSB = MPB + MEB
where:
- MSB = marginal social benefit
- MPB = marginal private benefit
- MEB = marginal external benefit
Supporting Formulae
Socially efficient allocation:
MSB = MSC
where:
- MSC = marginal social cost
Related Mathematical Methods
- Welfare economics
- Externality analysis
- Cost-benefit analysis
- Subsidy analysis
- Social welfare optimisation
- Cost-effectiveness analysis
Example
A vaccination programme provides a direct health benefit valued at �70 per vaccinated individual and an additional herd immunity benefit valued at �25 for the wider community.
The marginal social benefit is:
MSB = 70 + 25 = �95
If private individuals consider only the �70 private benefit, vaccination uptake will be lower than the socially efficient level, justifying public subsidy or government provision.
Excel Implementation
| Function | Example Formula | Health Economics Application |
|---|---|---|
| SUM | =B2+C2 | Calculates marginal social benefit by adding private and external benefits. |
| IF | =IF(D2>E2,""Intervention justified"",""Not justified"") | Compares social benefits with social costs for policy evaluation. |
| PRODUCT | =B2*C2 | Estimates total external benefits across affected individuals. |
| SUMPRODUCT | =SUMPRODUCT(ExternalBenefit,Population) | Calculates aggregate spillover benefits for population-level analyses. |
VBA (Optional)
Automate estimation of external health benefits across alternative intervention scenarios and generate social welfare analyses for public health policies.
Sources
- Pigou AC. The Economics of Welfare.
- Arrow KJ. Uncertainty and the welfare economics of medical care. American Economic Review. 1963;53(5):941?973.
- Varian HR. Intermediate Microeconomics: A Modern Approach.
- Folland S, Goodman AC, Stano M. The Economics of Health and Health Care.
- Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
Related Concepts (3)
Frequently Asked Questions (6)
What is a positive externality?
A benefit conferred on a third party by an economic activity, not reflected in its market price, leading to underproduction relative to the social optimum.
Source: Pigou 1920
How does a positive externality separate private and social benefit?
When an activity confers a benefit on others that the actor is not paid for, the benefit the actor sees, the private benefit, is smaller than the benefit to society, which includes the gain to third parties. Deciding on the private benefit alone, the actor treats the activity as less rewarding than it really is and does too little of it. This gap between private and social benefit is why activities with beneficial spillovers are undersupplied by a market. Baumol and Oates (1988) formalise this divergence.
Source: Baumol & Oates 1988
Why does a positive externality cause underproduction?
A positive externality causes underproduction because the producer or consumer considers only the benefit they themselves gain, ignoring the benefit conferred on others, so the private benefit lies below the true social benefit. Decisions are made as if the external benefit did not exist, so the activity is carried only to the level where private benefit equals private cost, short of the point where social benefit equals cost. The result is less of the activity than is socially efficient.
Source: Pigou 1920
What are examples of positive externalities?
Classic examples include education, which benefits society beyond the individual educated, and research, whose findings benefit others than the researcher. In health, vaccination confers a positive externality by reducing the risk of infection to others, and the treatment of communicable disease protects the wider community, benefits for which the individual is not paid. In each case an activity confers benefits on third parties that its price does not capture, so private demand falls short.
Source: Pigou 1920
How can a positive externality be corrected?
A positive externality can be corrected by making the decision maker share in the external benefit. Pigou proposed a subsidy equal to the external benefit, so that private benefit rises to the social benefit and the activity expands to the efficient level. Other remedies include public provision, mandates, and information campaigns. Each aims to internalise the external benefit, raising the activity from the level private incentives alone would produce toward the social optimum.
Source: Pigou 1920
What positive externalities occur in health?
Positive externalities in health arise chiefly through communicable disease. Vaccination protects not only the person vaccinated but others, by reducing transmission and contributing to herd immunity, and treating an infectious person protects those they might otherwise infect. Because individuals are not rewarded for these benefits to others, private demand for vaccination and treatment falls below the socially efficient level. This underprovision justifies subsidy, free provision, or mandates for such services, as the analysis of positive externalities implies.
Source: Pigou 1920
Trust Record
Verified by Dr Darrin Baines
British health economist
Professional identity: darrinbaines.org
Verification date: 11 Sep 2025
Content version: 1.0.0
Canonical Identity
- Term code
- HE-EE-ME-051
Stable URI · Machine-readable · Resolvable · CC BY 4.0